Both large pharmaceutical and emerging biotechnology companies face many obstacles and potential pitfalls in the drug development process. From early development stages to commercialization, many coordinated, cross-functional efforts are required to meet key milestones and keep a program on track.
A comprehensive development strategy and plan can provide a detailed roadmap on how to make critical development decisions, improve efficiency, reduce costs and even shorten timelines. By outlining a plan for advancing a program and meeting regulatory, nonclinical, clinical, commercial and CMC requirements, a company is better prepared to proactively mitigate common risks and improve the likelihood of successful regulatory approvals around the world.
Learn more about the essential components of a comprehensive drug development plan, which can provide a basis for sound investment decisions and enable project portfolio prioritization and management.